{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:49:33Z","timestamp":1792802973072,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Senescence refers to a cellular state marked by irreversible cell cycle arrest and the secretion of pro-inflammatory and tissue-remodeling factors. The senescence associated secretory phenotype (SASP) impacts the tissue microenvironment and provides cues for the immune system to eliminate senescent cells (SCs). Cellular senescence has a dual nature; it can be beneficial during embryonic development, tissue repair, and tumor suppression, but it can also be detrimental in the context of chronic stress, persistent tissue injury, together with an impairment in SC clearance. Recently, the accumulation of SCs has been implicated in the pathogenesis of pulmonary arterial hypertension (PAH), a progressive condition affecting the pre-capillary pulmonary arterial bed. PAH is characterized by endothelial cell (EC) injury, inflammation, and proliferative arterial remodeling, which leads to right heart failure and premature mortality. While vasodilator therapies can improve symptoms, there are currently no approved treatments capable of reversing the obliterative arterial remodeling. Ongoing endothelial injury and dysfunction is central to the development of PAH, perpetuated by hemodynamic perturbation leading to pathological intimal shear stress. The precise role of senescent ECs in PAH remains unclear. Cellular senescence may facilitate endothelial repair, particularly in the early stages of disease. However, in more advanced disease the accumulation of senescent ECs may promote vascular inflammation and occlusive arterial remodeling. In this review, we will examine the evidence that supports a role of endothelial cell senescence to the pathogenesis of PAH. Furthermore, we will compare and discuss the apparent contradictory outcomes with the use of interventions targeting cellular senescence in the context of experimental models of pulmonary hypertension. Finally, we will attempt to propose a framework for the understanding of the complex interplay between EC injury, senescence, inflammation and arterial remodeling, which can guide further research in this area and the development of effective therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1403669","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:26:25Z","timestamp":1722572785000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain"],"prefix":"10.3389","volume":"15","author":[{"given":"Elmira","family":"Safaie Qamsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-95","article-title":"Endothelial cells and pulmonary arterial hypertension: Apoptosis, proliferation, interaction and transdifferentiation","volume":"10","author":"Sakao","year":"2009","journal-title":"Respir Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.049","article-title":"Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease","volume":"49","author":"L\u00e9vy","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2018-0329TR","article-title":"Converging paths of pulmonary arterial hypertension and cellular senescence","volume":"61","author":"Van Der Feen","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx034","article-title":"Pulmonary arterial hypertension in congenital heart disease: Translational opportunities to study the reversibility of pulmonary vascular disease","volume":"38","author":"Van Der Feen","year":"2017","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4974","article-title":"Cellular senescence impairs the reversibility of pulmonary arterial hypertension","volume":"12","author":"Van Der Feen","year":"2020","journal-title":"Sci Transl Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.058794","article-title":"Eliminating senescent cells can promote pulmonary hypertension development and progression","volume":"147","author":"Born","year":"2023","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7110150","article-title":"Effects of Bcl-2\/Bcl-xL inhibitors on pulmonary artery smooth muscle cells","volume":"7","author":"Rybka","year":"2018","journal-title":"Antioxidants"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202012-4317SO","article-title":"Pulmonary arterial hypertension: Diagnosis, treatment, and novel advances","volume":"203","author":"Maron","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.18261","article-title":"Evolving concepts in endothelial pathobiology of pulmonary arterial hypertension","volume":"79","author":"Cober","year":"2022","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319815","article-title":"Endothelial senescence: A new age in pulmonary hypertension","volume":"130","author":"Culley","year":"2022","journal-title":"Circ Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab296","article-title":"Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension","volume":"118","author":"Rodor","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01552-2021","article-title":"Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC\/ERS guideline era","volume":"59","author":"Zelt","year":"2022","journal-title":"Eur Respir J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S236743","article-title":"Novel experimental therapies for treatment of pulmonary arterial hypertension","volume":"13","author":"Zolty","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00739-0","article-title":"Mechanisms and consequences of endothelial cell senescence","volume":"20","author":"Bloom","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72449","article-title":"The right time for senescence","volume":"10","author":"De-Carvalho","year":"2021","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6659","article-title":"Senescent intimal foam cells are deleterious at all stages of atherosclerosis","volume":"354","author":"Childs","year":"2016","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: Aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006429","article-title":"Endothelial cell heterogeneity","volume":"2","author":"Aird","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8265-z","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","volume":"44","author":"Kherbeck","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.241299","article-title":"Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease","volume":"109","author":"Noureddine","year":"2011","journal-title":"Circ Res"},{"key":"B30","article-title":"Endothelial cell senescence exacerbates pulmonary fibrosis potentially through accelerated endothelial to mesenchymal transition","volume":"67","author":"Ramadhiani","year":"2021","journal-title":"Kobe J Med Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2023-0038OC","article-title":"Cellular senescence contributes to the progression of hyperoxic bronchopulmonary dysplasia","volume":"70","author":"Jing","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201709-756FR","article-title":"Respiratory phenotypes for preterm infants, children, and adults: Bronchopulmonary dysplasia and more","volume":"15","author":"Collaco","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging","volume":"169","author":"Baar","year":"2017","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00538.2017","article-title":"Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension","volume":"316","author":"Wang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0802OC","article-title":"Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease","volume":"184","author":"Amsellem","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136459","article-title":"Frataxin deficiency promotes endothelial senescence in pulmonary hypertension","volume":"131","author":"Culley","year":"2021","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1086\/688774","article-title":"In situ expression of bcl-2 in pulmonary artery endothelial cells associates with pulmonary arterial hypertension relative to heart failure with preserved ejection fraction","volume":"6","author":"Benza","year":"2016","journal-title":"Pulm Circ"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/10409230600846058","article-title":"The structure and function of frataxin","volume":"41","author":"Bencze","year":"2006","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149721","article-title":"Frataxin and endothelial cell senescence in pulmonary hypertension","volume":"131","author":"Lawrie","year":"2021","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106662","article-title":"Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells","volume":"26","author":"Ramadhiani","year":"2023","journal-title":"iScience"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94097-5","article-title":"Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis","volume":"11","author":"Honda","year":"2021","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14387-w","article-title":"Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype","volume":"11","author":"Barinda","year":"2020","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319971","article-title":"The latest in animal models of pulmonary hypertension and right ventricular failure","volume":"130","author":"Boucherat","year":"2022","journal-title":"Circ Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw070","article-title":"Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension","volume":"111","author":"Abe","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.16.562339","article-title":"Vicious cycle of hemodynamic perturbation and endothelial injury in development and progression of pulmonary arterial hypertension Short Title: Arteriolar loss and hemodynamic stress in PAH progression","author":"Deng","year":""},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.85.1.380","article-title":"Autoimmune disease and unexplained pulmonary hypertension","volume":"85","author":"Rabinovitch","year":"1992","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201601-0113ED","article-title":"Shear stress maladaptation in pulmonary arterial hypertension: An ageless concept","volume":"193","author":"Bonnet","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v9i11","article-title":"TNF\u03b1-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion","volume":"9","author":"Kandhaya-Pillai","year":"2017","journal-title":"Aging"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006167","article-title":"Role for DNA damage signaling in pulmonary arterial hypertension","volume":"129","author":"Meloche","year":"2014","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120847","article-title":"Mitochondrial metabolism in pulmonary hypertension: Beyond mountains there are mountains","volume":"128","author":"Culley","year":"2018","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810234","article-title":"Targeting senescent cells in translational medicine","volume":"11","author":"Paez-Ribes","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneph.2016.166","article-title":"Ageing: Targeting senescence-associated tissue damage","volume":"13","author":"Allison","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/gad.332643.119","article-title":"The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice","volume":"34","author":"Ritschka","year":"2020","journal-title":"Genes Dev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2023-0436ED","article-title":"Getting the timing right: controlling BCL-2 inhibition as an anti-fibrotic therapy","volume":"70","author":"Cooley","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0429OC","article-title":"Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension","volume":"48","author":"Houssaini","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v7i34","article-title":"Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1086\/674311","article-title":"Everolimus in patients with severe pulmonary hypertension: A safety and efficacy pilot trial","volume":"3","author":"Seyfarth","year":"2013","journal-title":"Pulm Circ"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201703-0502OC","article-title":"ASK1 inhibition halts disease progression in preclinical models of pulmonary arterial hypertension","volume":"197","author":"Budas","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00032-1","article-title":"Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"10","author":"Rosenkranz","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00038.2015","article-title":"The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: A potential novel anti-inflammatory strategy in pulmonary hypertension","volume":"309","author":"Church","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00977.2008","article-title":"Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction","volume":"296","author":"Weerackody","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.03.003","article-title":"Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats","volume":"128","author":"Lu","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2015.1111235","article-title":"Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension","volume":"44","author":"Rice","year":"2016","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3892\/etm","article-title":"Interventions and mechanisms of N-acetylcysteine on monocrotaline-induced pulmonary arterial hypertension","volume":"15","author":"Yu","year":"2018","journal-title":"Exp Ther Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201812-2275OC","article-title":"Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension","volume":"200","author":"Van Der Feen","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.307004","article-title":"Bromodomain-containing protein 4: The epigenetic origin of pulmonary arterial hypertension","volume":"117","author":"Meloche","year":"2015","journal-title":"Circ Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1631LE","article-title":"IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: A single-arm, open-label, phase Ib\/II pilot study","volume":"199","author":"Trankle","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.11.6.7946395","article-title":"Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline","volume":"11","author":"Voelkel","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01448-2015","article-title":"Role of interleukin-1 receptor 1\/MyD88 signalling in the development and progression of pulmonary hypertension","volume":"48","author":"Parpaleix","year":"2016","journal-title":"Eur Respir J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02463-2020","article-title":"Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension","volume":"59","author":"Toshner","year":"2022","journal-title":"Eur Respir J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.07.006","article-title":"Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-\u03b1 antagonists via the suppression of TNF-\u03b1 expression and NF-\u03baB pathway in rats","volume":"58","author":"Wang","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12304","article-title":"Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension","volume":"19","author":"Zhang","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14079","article-title":"TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2006.26.661","article-title":"Etanercept reduces late endotoxin-induced pulmonary hypertension in the pig","volume":"26","author":"Mutschler","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1242\/dev.151837","article-title":"Cellular senescence in development, regeneration and disease","volume":"146","author":"Rhinn","year":"2019","journal-title":"Dev (Cambridge)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030671","article-title":"Immune clearance of senescent cells to combat ageing and chronic diseases","volume":"9","author":"Song","year":"2020","journal-title":"Cells"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"135","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2018.02.001","article-title":"Cellular senescence: Immunosurveillance and future immunotherapy","volume":"43","author":"Burton","year":"2018","journal-title":"Ageing Res Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.medj.2021.04.014","article-title":"Invariant natural killer T cells coordinate removal of senescent cells","volume":"2","author":"Arora","year":"2021","journal-title":"Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","article-title":"Senescent cell clearance by the immune system: Emerging therapeutic opportunities","volume":"40","author":"Prata","year":"2018","journal-title":"Semin Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition","volume":"10","author":"Pereira","year":"2019","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00712-x","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124716","article-title":"Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging","volume":"4","author":"Mu\u00f1oz","year":"2019","journal-title":"JCI Insight"},{"key":"B86","doi-asserted-by":"publisher","first-page":"113951","DOI":"10.1016\/j.bcp.2020.113951","article-title":"Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK\/SIRT1\/Nrf2 signaling pathway","volume":"177","author":"Chen","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1101\/gad.302570.117","article-title":"Identification of senescent cell surface targetable protein DPP4","volume":"31","author":"Kim","year":"2017","journal-title":"Genes Dev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v8i2","article-title":"NKG2D ligands mediate immunosurveillance of senescent cells","volume":"8","author":"Sagiv","year":"2016","journal-title":"Aging"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.206","article-title":"Granule exocytosis mediates immune surveillance of senescent cells","volume":"32","author":"Sagiv","year":"2013","journal-title":"Oncogene"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07825-3","article-title":"Impaired immune surveillance accelerates accumulation of senescent cells and aging","volume":"9","author":"Ovadya","year":"2018","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1403669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:26:29Z","timestamp":1722572789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1403669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2024.1403669"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1403669","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"article-number":"1403669"}}